跳至主要内容
临床试验/NL-OMON24642
NL-OMON24642招募中不适用

A Prospective Observational Study of Treatment Options in Men with metastatic hormone sensitive prostate cancer (mHSPC)

Janssen-Cilag B.V.0 个研究点目标入组 450 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
450

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • Male, 18 years or older aged
  • Must have a confirmed newly diagnosis of metastatic hormone sensitive prostate cancer.
  • Must sign a participation agreement/ICF allowing data collection and source data verification in accordance with local requirements

排除标准

  • Currently enrolled in an investigational interventional study
  • Currently enrolled in an observational study sponsored or managed by a Janssen company
  • Patients with insufficient understanding of the Dutch language or cognitive impairment that impede proper answering of the questionnaires

研究者

相似试验